AMIE MICHELLE JAKUBIAK

Allopathic & Osteopathic Physicians|Family Medicine GREENVILLE, SC NPI 1891779385

General Payments — all program years on this page

$463.83

  • Category: General Payments
  • Program years: PY2024
  • Record count: 18
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $463.83 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $463.8318

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $166.756
Lilly USA, LLC $161.903
Bayer HealthCare Pharmaceuticals Inc. $57.964
Novo Nordisk AS $48.893
Exact Sciences Corporation $14.561
ABBVIE INC. $13.771

By program year

Program yearAmountRecords
2024 $463.8318

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086114736 Bayer Healthcare Pharmaceuticals Inc. $14.57 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086131524 Bayer Healthcare Pharmaceuticals Inc. $14.25 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086166746 Bayer Healthcare Pharmaceuticals Inc. $14.57 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086195652 Bayer Healthcare Pharmaceuticals Inc. $14.57 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096881342 Novo Nordisk Inc $19.55 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096938499 Novo Nordisk Inc $13.83 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097031273 Novo Nordisk Inc $15.51 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103984420 ABBVIE INC. $13.77 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104252711 AstraZeneca Pharmaceuticals LP $13.95 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104648813 AstraZeneca Pharmaceuticals LP $17.98 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105232453 AstraZeneca Pharmaceuticals LP $90.88 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105500274 AstraZeneca Pharmaceuticals LP $19.17 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105520945 AstraZeneca Pharmaceuticals LP $9.92 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105712534 AstraZeneca Pharmaceuticals LP $14.85 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114716573 Exact Sciences Corporation $14.56 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136029707 Lilly USA, LLC $122.74 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136030576 Lilly USA, LLC $20.78 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136030578 Lilly USA, LLC $18.38 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.